Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 7, pp. 1423-1435
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 13, 2019
- Revision received February 17, 2020
- Accepted April 6, 2020
- Published first May 5, 2020.
Article Versions
- Previous version (May 5, 2020 - 07:57).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Charlotte K. Milton1,
- Annette J. Self1,
- Paul A. Clarke1,
- Udai Banerji1,2,
- Federica Piccioni3,
- David E. Root3, and
- Steven R. Whittaker1,*
- 1Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
- 2The Royal Marsden NHS Foundation Trust, London, United Kingdom.
- 3The Broad Institute, Cambridge, Massachusetts.
- ↵*Corresponding Author:
Steven R. Whittaker, The Institute of Cancer Research, London SW7 3RP, United Kingdom. Phone: 4420-8722-4220; Fax: 4420-8770-7899; E-mail: steven.whittaker{at}gmail.com
July 2020
Volume 19, Issue 7
Volume 19, Issue 7
A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer
Jump to section
Advertisement